190 related articles for article (PubMed ID: 21546836)
21. [Calcium supplementation and the possible increase in cardiovascular risk].
Montero Sáez A; Formiga F; Pujol Farriols R
Rev Esp Geriatr Gerontol; 2013; 48(3):130-8. PubMed ID: 23523304
[TBL] [Abstract][Full Text] [Related]
22. Making sense of the latest advice on vitamin D therapy.
Monk RD; Bushinsky DA
J Am Soc Nephrol; 2011 Jun; 22(6):994-8. PubMed ID: 21617120
[TBL] [Abstract][Full Text] [Related]
23. Shining D' light on chronic kidney disease: mechanisms that may underpin the cardiovascular benefit of vitamin D.
Petchey WG; Johnson DW; Isbel NM
Nephrology (Carlton); 2011 May; 16(4):351-67. PubMed ID: 21323790
[TBL] [Abstract][Full Text] [Related]
24. Evidence that calcium supplements reduce fracture risk is lacking.
Seeman E
Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S3-11. PubMed ID: 20089500
[TBL] [Abstract][Full Text] [Related]
25. Calcium supplementation: cardiovascular risk?
Prescrire Int; 2013 Jun; 22(139):152-3. PubMed ID: 23866352
[TBL] [Abstract][Full Text] [Related]
26. Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population.
West SL; Swan VJ; Jamal SA
Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S41-7. PubMed ID: 20089502
[TBL] [Abstract][Full Text] [Related]
27. The dual vitamin D pathways: considerations for adequate supplementation.
Cronin SC
Nephrol Nurs J; 2010; 37(1):19-26, 36; quiz 27-8. PubMed ID: 20333900
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular effects of calcium supplementation.
Reid IR; Bolland MJ; Avenell A; Grey A
Osteoporos Int; 2011 Jun; 22(6):1649-58. PubMed ID: 21409434
[TBL] [Abstract][Full Text] [Related]
29. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window.
Querfeld U; Mak RH
Pediatr Nephrol; 2010 Dec; 25(12):2413-30. PubMed ID: 20567854
[TBL] [Abstract][Full Text] [Related]
31. Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition.
Barnard K; Colón-Emeric C
Am J Geriatr Pharmacother; 2010 Feb; 8(1):4-33. PubMed ID: 20226390
[TBL] [Abstract][Full Text] [Related]
32. Calcium supplementation in osteoporosis: useful or harmful?
Chiodini I; Bolland MJ
Eur J Endocrinol; 2018 Apr; 178(4):D13-D25. PubMed ID: 29440373
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic interventions for chronic kidney disease-mineral and bone disorders: focus on mortality.
Block GA
Curr Opin Nephrol Hypertens; 2011 Jul; 20(4):376-81. PubMed ID: 21519253
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
Gutiérrez OM
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
[TBL] [Abstract][Full Text] [Related]
35. Assessing the potential adverse consequences of supplemental calcium on cardiovascular outcomes: should we change our approach to bone health?
Rojas-Fernandez CH; Maclaughlin EJ; Dore NL; Ebsary S
Ann Pharmacother; 2012 May; 46(5):696-702. PubMed ID: 22570431
[TBL] [Abstract][Full Text] [Related]
36. Calcium supplementation and vitamin D: a trigger for adverse cardiovascular events?
Zittermann A; Pilz S; Börgermann J; Gummert JF
Future Cardiol; 2011 Nov; 7(6):725-7. PubMed ID: 22050056
[No Abstract] [Full Text] [Related]
37. Vitamin D and Calcium Supplements: Helpful, Harmful, or Neutral for Cardiovascular Risk?
Heravi AS; Michos ED
Methodist Debakey Cardiovasc J; 2019; 15(3):207-213. PubMed ID: 31687100
[TBL] [Abstract][Full Text] [Related]
38. Randomized controlled trial of the effects of calcium with or without vitamin D on bone structure and bone-related chemistry in elderly women with vitamin D insufficiency.
Zhu K; Bruce D; Austin N; Devine A; Ebeling PR; Prince RL
J Bone Miner Res; 2008 Aug; 23(8):1343-8. PubMed ID: 18410225
[TBL] [Abstract][Full Text] [Related]
39. Bone mineral metabolism in patients with neurofibromatosis type 1 (von Recklingausen disease).
Petramala L; Giustini S; Zinnamosca L; Marinelli C; Colangelo L; Cilenti G; Formicuccia MC; D'Erasmo E; Calvieri S; Letizia C
Arch Dermatol Res; 2012 May; 304(4):325-31. PubMed ID: 22120694
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD.
Agarwal R
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1523-8. PubMed ID: 19478099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
